Literature DB >> 2190276

The natural history of diabetic nephropathy.

K R Tuttle1, J H Stein, R A DeFronzo.   

Abstract

Diabetic nephropathy is now the most common cause of ESRD in the US, and no other complication of diabetes is associated with more deaths. In addition to its impact on morbidity and mortality, it extracts a tremendous cost from the health-care economy. Prevention and better treatment of diabetic renal disease should be a high priority for both the health-care system and society at large. Ultimately, diabetic nephropathy should be preventable, but that goal can be accomplished only by the coordinated efforts between investigators, who work to uncover pathophysiologic processes and design new treatments, and clinicians, who take those findings to the patient's bedside.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2190276

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  4 in total

1.  Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014.

Authors:  Maryam Afkarian; Leila R Zelnick; Yoshio N Hall; Patrick J Heagerty; Katherine Tuttle; Noel S Weiss; Ian H de Boer
Journal:  JAMA       Date:  2016-08-09       Impact factor: 56.272

2.  Sodium-Glucose Cotransporter 2 Inhibitors and the Kidney.

Authors:  Ralph A DeFronzo; Muhammad Abdul-Ghani
Journal:  Diabetes Spectr       Date:  2021-08-18

Review 3.  The relationship between glucose control and the development and progression of diabetic nephropathy.

Authors:  Carrie A Phillips; Mark E Molitch
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

4.  The effect of chronic candesartan therapy on the metabolic profile and renal tissue cytokine levels in the obese Zucker rat.

Authors:  Carolyn M Ecelbarger; Arjun Rash; Rajesh K Sinha; Swasti Tiwari
Journal:  Mediators Inflamm       Date:  2010-05-17       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.